Related Experiment Video
Updated: Sep 3, 2025

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
β-Adrenergic Receptor Stimulation Maintains NCX-CaMKII Axis and Prevents Overactivation of IL6R-Signaling in
Ingrid Matzer1, Julia Voglhuber1,2, Mara Kiessling1
1Department of Cardiology, Medical University of Graz, 8036 Graz, Austria.
Abstract:
Excessive β-adrenergic stimulation and tachycardia are potent triggers of cardiac remodeling; however, their exact cellular effects remain elusive. Here, we sought to determine the potency of β-adrenergic stimulation and tachycardia to modulate gene expression profiles of cardiomyocytes. Using neonatal rat ventricular cardiomyocytes, we showed that tachycardia caused a significant upregulation of sodium-calcium exchanger (NCX) and the activation of calcium/calmodulin-dependent kinase II (CaMKII) in the nuclear region. Acute isoprenaline treatment ameliorated NCX-upregulation and potentiated CaMKII activity, specifically on the sarcoplasmic reticulum and the nuclear envelope, while preincubation with the β-blocker propranolol abolished both isoprenaline-mediated effects. On a transcriptional level, screening for hypertrophy-related genes revealed tachycardia-induced upregulation of interleukin-6 receptor (IL6R). While isoprenaline prevented this effect, pharmacological intervention with propranolol or NCX inhibitor ORM-10962 demonstrated that simultaneous CaMKII activation on the subcellular Ca2+ stores and prevention of NCX upregulation are needed for keeping IL6R activation low. Finally, using hypertensive Dahl salt-sensitive rats, we showed that blunted β-adrenergic signaling is associated with NCX upregulation and enhanced IL6R signaling. We therefore propose a previously unrecognized protective role of β-adrenergic signaling, which is compromised in cardiac pathologies, in preventing IL6R overactivation under increased workload. A better understanding of these processes may contribute to refinement of therapeutic options for patients receiving β-blockers.
Insights
Excessive beta-adrenergic stimulation and tachycardia can harm the heart. This study reveals beta-adrenergic signaling protects against interleukin-6 receptor (IL6R) overactivation during increased workload, a finding crucial for heart disease therapies.
Area of Science:
- Cardiology
- Molecular Biology
- Cellular Physiology
Background:
- Excessive beta-adrenergic stimulation and tachycardia are known triggers of cardiac remodeling.
- The precise cellular mechanisms underlying these effects on cardiomyocyte gene expression are not fully understood.
Purpose of the Study:
- To investigate the impact of beta-adrenergic stimulation and tachycardia on cardiomyocyte gene expression profiles.
- To elucidate the role of sodium-calcium exchanger (NCX) and calcium/calmodulin-dependent kinase II (CaMKII) in cardiac remodeling.
- To explore the protective function of beta-adrenergic signaling in preventing cardiac pathology.
Main Methods:
- Utilized neonatal rat ventricular cardiomyocytes and hypertensive Dahl salt-sensitive rats.
- Assessed gene expression, including interleukin-6 receptor (IL6R).
- Employed pharmacological interventions: isoprenaline, propranolol, and an NCX inhibitor (ORM-10962).
Main Results:
- Tachycardia upregulated sodium-calcium exchanger (NCX) and activated nuclear calcium/calmodulin-dependent kinase II (CaMKII).
- Isoprenaline ameliorated NCX upregulation and modulated CaMKII activity.
- Tachycardia induced interleukin-6 receptor (IL6R) upregulation, which was prevented by isoprenaline but required simultaneous CaMKII activation and NCX inhibition.
- Blunted beta-adrenergic signaling in hypertensive rats correlated with NCX upregulation and enhanced IL6R signaling.
Conclusions:
- Beta-adrenergic signaling plays a protective role by preventing interleukin-6 receptor (IL6R) overactivation under increased cardiac workload.
- This protective mechanism is compromised in cardiac pathologies.
- Understanding these pathways can inform therapeutic strategies, particularly for patients on beta-blockers.
More Related Videos
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
cAMP-dependent Protein Kinase Pathways
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
G-Protein Gated Ion Channels
Sensory...